{"id":"37ec1fa37e63","type":"article","url":"https://hartvaat.nl/2026/04/24/grote-ziekenhuisvariatie-in-mcs-gebruik-bij-myocardinfarct-met-cardiogene-shock/","title":"Grote ziekenhuisvariatie in MCS-gebruik bij myocardinfarct met cardiogene shock","title_en":"","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":["acuut-hartfalen","cardiogene-shock","myocardinfarct"],"journal":"Heart","doi":"http://heart.bmj.com/cgi/content/short/112/10/563?rss=1","source_url":"https://doi.org/http://heart.bmj.com/cgi/content/short/112/10/563?rss=1","authors":["Verma","A.","Chervu","N. L.","Kim","J. J.","Mallick","S.","Ziaeian","B.","Benharash","P."],"significance":6,"published":"2026-05-10","source_date":"2026-04-24","image":"https://hartvaat.nl/global/img/54665943e7e6.webp","kennis":["https://hartvaat.nl/kennis/antistolling/doac-versus-vka-keuze/","https://hartvaat.nl/kennis/coronairlijden/stemi/"],"congress":"","summary_en":"An analysis of the 2019 Nationwide Readmissions Database examined inter-hospital variation in intra-aortic balloon pump (IABP) versus percutaneous ventricular assist device (PVAD) use in adults with AMI complicated by cardiogenic shock. Large inter-hospital differences in device choice were observed, not fully explained by patient factors. Institutional characteristics (volume, academic affiliation) emerged as key determinants — underscoring the need for standardised algorithms for MCS deployment in AMI cardiogenic shock.","created":"2026-07-03T10:32:53Z","updated":"2026-07-03T13:31:48Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Analyse van de Nationwide Readmissions Database 2019 onderzocht ziekenhuisvariatie in gebruik van intra-aortale ballonpomp (IABP) versus percutaan ventricular assist device (PVAD) bij volwassenen met acuut myocardinfarct gecompliceerd door cardiogene shock. Er werden grote interhospitale verschillen in apparaatkeuze gevonden, niet volledig verklaard door patiëntfactoren. Institutionele kenmerken (volume, academisch profiel) kwamen naar voren als belangrijke determinanten — wat de noodzaak onderstreept van gestandaardiseerde algoritmes voor MCS-inzet bij AMI-shock.","abstract_original":"Background\n

Cardiogenic shock (CS) is a leading cause of mortality following acute myocardial infarction (AMI). Some patients may require intra-aortic balloon pump (IABP) or percutaneous ventricular assist device (PVAD) placement; however, there is a paucity of standardised algorithms to guide the deployment of each device. The present study evaluated interhospital variation in the use of IABP and PVAD for AMI CS and identified institutional factors associated with hospital-level device preference.

\n\nMethods\n

All non-elective adult hospitalisations entailing AMI and CS were identified within the 2019 Nationwide Readmissions Database. Patients were grouped into IABP, PVAD and non-mechanical circulatory support cohorts. The primary aim was to quantify the degree of interhospital variation in the use of IABP and PVAD. Escalation to extracorporeal membrane oxygenation (ECMO), left ventricular assist device (LVAD) implantation, length of stay and hos"}